ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 616348 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 616348; 2) Community: the network communities that were significantly associated with the response to NSC 616348; 3) Molecule: the relationships between components within communities and NSC 616348; 4) MDR: the compounds that were significantly associated with the NSC 616348.

NSC Compound Enrichment Correlation
NSC 753665 Null 0.0090516764346157 0.31209184
NSC 634036 4-amino-3-bromo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazin-7-one 0.0100995289754787 0.24169484
NSC 639174 Camptothecin Derivative 0.0100995289754787 0.79012269
NSC 639186 Raltitrexed 0.0100995289754787 0.6346779
NSC 659162 1H-Benzimidazole, 5,5'-dithiobis[2-(trifluoromethyl)- (9CI) 0.0100995289754787 0.24963703
NSC 678879 Null 0.0100995289754787 0.24304226
NSC 679287 Null 0.0100995289754787 0.33947111
NSC 681639 Camptothecin Derivative 0.0100995289754787 0.81851637
NSC 683414 Null 0.0100995289754787 0.74735722
NSC 693885 1-Propanone, 1-chloro-2-methyl-, O-[[(4-fluoro- 3-nitrophenyl)amino]carbonyl]oxime 0.0100995289754787 0.29110246
Total:98  Current:26    [First] [Prev] [Next] [Last]